ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

4.94
0.01
(0.20%)
Closed February 03 3:00PM
4.94
0.00
( 0.00% )
Pre Market: 3:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
4.94
Bid
4.81
Ask
6.08
Volume
-
0.00 Day's Range 0.00
4.275 52 Week Range 11.555
Market Cap
Previous Close
4.94
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,880,424
Shares Outstanding
252,527,585
Dividend Yield
-
PE Ratio
-10.48
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$4.94. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.275 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares outstanding. The market capitalization of Maravai LifeSciences is US$1.25 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -10.48.

MRVI Latest News

TriLink BioTechnologies® entre en partenariat avec Avantor® pour étendre ses solutions d'acides nucléiques en Europe

Le partenariat rationalise le processus de commande et réduit les délais pour soutenir intégralement les projets des clients européens de TriLink TriLink BioTechnologies (TriLink®), une société...

TriLink BioTechnologies® geht Partnerschaft mit Avantor® ein, um Verfügbarkeit von Nukleinsäure-Lösungen in Europa zu erweitern

Die Partnerschaft optimiert den Bestellprozess und verkürzt die Vorlaufzeiten, um die europäischen Kundenprojekte von TriLink von Anfang bis Ende zu unterstützen TriLink BioTechnologies...

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

Partnership streamlines ordering process & reduces lead times to support TriLink’s European customer projects from start to finish TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences...

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies

Molecular Assemblies proprietary Fully Enzymatic SynthesisTM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business Maravai...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.85-14.68048359245.796.054.7122316245.0859614CS
4-1.01-16.9747899165.956.214.3822453715.07813191CS
12-0.76-13.33333333335.76.344.27518804245.2552855CS
26-3.96-44.49438202258.99.954.27520200336.99721318CS
52-0.26-55.211.5554.27521607437.56720091CS
156-24.2-83.047357584129.1441.824.275208869613.64675596CS
260-26.17-84.120861459331.1163.554.275191453419.13950002CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?
The current share price of Maravai LifeSciences is US$ 4.94
How many Maravai LifeSciences shares are in issue?
Maravai LifeSciences has 252,527,585 shares in issue
What is the market cap of Maravai LifeSciences?
The market capitalisation of Maravai LifeSciences is USD 1.25B
What is the 1 year trading range for Maravai LifeSciences share price?
Maravai LifeSciences has traded in the range of US$ 4.275 to US$ 11.555 during the past year
What is the PE ratio of Maravai LifeSciences?
The price to earnings ratio of Maravai LifeSciences is -10.48
What is the cash to sales ratio of Maravai LifeSciences?
The cash to sales ratio of Maravai LifeSciences is 4.27
What is the reporting currency for Maravai LifeSciences?
Maravai LifeSciences reports financial results in USD
What is the latest annual turnover for Maravai LifeSciences?
The latest annual turnover of Maravai LifeSciences is USD 292.23M
What is the latest annual profit for Maravai LifeSciences?
The latest annual profit of Maravai LifeSciences is USD -119.03M
What is the registered address of Maravai LifeSciences?
The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Maravai LifeSciences operate in?
Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 212.46
(36.79%)
16.13k
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 45.03
(36.50%)
31.58k
IVVDInvivyd Inc
US$ 1.32
(24.53%)
1.82M
EVAXEvaxion Biotech AS
US$ 2.98
(24.17%)
349.2k
PLTRPalantir Technologies Inc
US$ 99.40
(18.70%)
384.04k
UOKAMDJM Ltd
US$ 0.1759
(-26.09%)
140.57k
EJHE Home Household Service Holdings Ltd
US$ 0.7857
(-22.97%)
2.43k
BCTXBriaCell Therapeutics Corporation
US$ 4.00
(-20.63%)
2.27k
FHTXFoghorn Therapeutics Inc
US$ 3.21
(-19.35%)
2.5k
NCEWNew Century Logistics BVI Ltd
US$ 1.56
(-19.17%)
3
IVVDInvivyd Inc
US$ 1.32
(24.53%)
1.82M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0409
(-11.47%)
751.82k
PLTRPalantir Technologies Inc
US$ 99.40
(18.70%)
384.04k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1861
(-4.52%)
374.72k
EVAXEvaxion Biotech AS
US$ 2.98
(24.17%)
349.2k

MRVI Discussion

View Posts
Monksdream Monksdream 11 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 11 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock